Efficacy and safety of NRTI¿s switch to tenofovir plus emtricitabine (Truvada(R)) vs. abacavir plus lamivudine (Kivexa(R)) in patients with virologic suppression receiving a lamivudine containing HAART: the BICOMBO study Conference Paper 2007 Congress communication uri icon

authors

  • and BICOMBO Study Group
  • Arranz JA
  • GUTIERREZ RODERO, FELIX
  • Knobel H
  • Llibre JM
  • Martinez E
  • Podzamczer D
  • Ribera E
  • Roca V

publication date

  • 2007